Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras GTPase-activating protein-binding protein 1 (G3BP1) mRNA encodes a multifunctional RNA-binding protein that serves as the primary nucleator for the assembly of stress granules (SGs) (PubMed: 31064744). Stress granules are membrane-less organelles that sequester mRNAs and proteins during cellular stress to regulate protein synthesis and cell survival (UniProt: Q13283). In many cancers, G3BP1 is upregulated and promotes tumor cell proliferation, invasion, and resistance to apoptosis by stabilizing oncogenic mRNAs (PubMed: 32814841). Furthermore, G3BP1 is a critical host factor for various viruses, including SARS-CoV-2, which utilize it to facilitate viral genome replication or to suppress host antiviral signaling pathways like the cGAS-STING pathway (PubMed: 33053439). Targeting G3BP1 mRNA with nucleic acid-based therapeutics, such as antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs), provides a strategy to deplete G3BP1 protein levels, thereby inhibiting SG formation and disrupting the survival mechanisms of cancer cells and viruses (PubMed: 34206035). This approach is particularly relevant in overcoming chemoresistance and treating viral infections where G3BP1 is a mandatory co-factor. Research is also exploring the role of G3BP1 in neurodegenerative diseases, where aberrant stress granule formation is a hallmark of pathology (PubMed: 31064744).
Degradation of target mRNA via RNase H-mediated cleavage or RNA interference (RNAi) to reduce G3BP1 protein expression.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras GTPase-activating protein-binding protein 1 (G3BP1) mRNA (G3BP1 mRNA).